位置:首页 > 蛋白库 > COMQ_BACSC
COMQ_BACSC
ID   COMQ_BACSC              Reviewed;         279 AA.
AC   P0DV09; Q8VLM0;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   23-FEB-2022, sequence version 1.
DT   03-AUG-2022, entry version 3.
DE   RecName: Full=Tryptophan prenyltransferase ComQ {ECO:0000305};
DE            EC=2.5.1.- {ECO:0000269|PubMed:22197102, ECO:0000269|PubMed:25036949, ECO:0000269|PubMed:31670609};
DE   AltName: Full=Pre-ComX modifying enzyme {ECO:0000305};
GN   Name=comQ {ECO:0000303|PubMed:12067344};
OS   Bacillus spizizenii (Bacillus subtilis subsp. spizizenii).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=96241;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=RO-E-2 / NRRL B-23055;
RX   PubMed=12067344; DOI=10.1046/j.1365-2958.2002.02977.x;
RA   Ansaldi M., Marolt D., Stebe T., Mandic-Mulec I., Dubnau D.;
RT   "Specific activation of the Bacillus quorum-sensing systems by
RT   isoprenylated pheromone variants.";
RL   Mol. Microbiol. 44:1561-1573(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=DV3-D-2 / NRRL B-23063;
RA   Sabotic J., Cepon U., Cadez P., Mandic Mulec I.;
RT   "Variability of Bacillus sp. quorum sensing system.";
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=RO-E-2 / NRRL B-23055;
RX   PubMed=22197102; DOI=10.1016/j.febslet.2011.12.012;
RA   Tsuji F., Ishihara A., Kurata K., Nakagawa A., Okada M., Kitamura S.,
RA   Kanamaru K., Masuda Y., Murakami K., Irie K., Sakagami Y.;
RT   "Geranyl modification on the tryptophan residue of ComXRO-E-2 pheromone by
RT   a cell-free system.";
RL   FEBS Lett. 586:174-179(2012).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF LYS-182; 183-GLN-LEU-184;
RP   ASN-186; ASP-187; TYR-188; TYR-189 AND GLY-190.
RC   STRAIN=RO-E-2 / NRRL B-23055;
RX   PubMed=25036949; DOI=10.1080/09168451.2014.891932;
RA   Okada M., Ishihara A., Yamasaki R., Tsuji F., Hayashi S., Usami S.,
RA   Sakagami Y.;
RT   "A region corresponding to second aspartate-rich motif in tryptophan
RT   isoprenylating enzyme, ComQ, serves as a substrate-binding site.";
RL   Biosci. Biotechnol. Biochem. 78:550-555(2014).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ILE-49; PHE-63; ASP-68;
RP   THR-92; PRO-134; THR-152; ASN-186; GLY-190; LYS-202; SER-234 AND GLU-248.
RC   STRAIN=RO-E-2 / NRRL B-23055;
RX   PubMed=31670609; DOI=10.1080/09168451.2019.1685371;
RA   Hirooka K., Shioda S., Okada M.;
RT   "Identification of critical residues for the catalytic activity of ComQ, a
RT   Bacillus prenylation enzyme for quorum sensing, by using a simple bioassay
RT   system.";
RL   Biosci. Biotechnol. Biochem. 84:347-357(2020).
CC   -!- FUNCTION: Part of a major quorum-sensing system that regulates the
CC       development of genetic competence (PubMed:22197102). Involved in the
CC       maturation of the competence pheromone ComX (PubMed:22197102,
CC       PubMed:25036949). Acts by catalyzing the transfer of a geranyl group on
CC       the ComX pheromone (PubMed:22197102, PubMed:25036949, PubMed:31670609).
CC       Cannot use farnesyl diphosphate (FPP) (PubMed:31670609).
CC       {ECO:0000269|PubMed:22197102, ECO:0000269|PubMed:25036949,
CC       ECO:0000269|PubMed:31670609}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-geranyl diphosphate + L-tryptophyl-[protein] = (2S,3R)-3-
CC         geranyl-2,3-dihydro-2,N(alpha)-cyclo-L-tryptophyl-[protein] +
CC         diphosphate; Xref=Rhea:RHEA:59492, Rhea:RHEA-COMP:15365, Rhea:RHEA-
CC         COMP:15366, ChEBI:CHEBI:29954, ChEBI:CHEBI:33019, ChEBI:CHEBI:58057,
CC         ChEBI:CHEBI:141127; Evidence={ECO:0000269|PubMed:22197102,
CC         ECO:0000269|PubMed:25036949, ECO:0000269|PubMed:31670609};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59493;
CC         Evidence={ECO:0000269|PubMed:22197102, ECO:0000269|PubMed:25036949,
CC         ECO:0000269|PubMed:31670609};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:22197102};
CC       Note=Binds 2 Mg(2+) ions per subunit. {ECO:0000250|UniProtKB:P14324};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 8.0-9.5. {ECO:0000269|PubMed:22197102};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius.
CC         {ECO:0000269|PubMed:22197102};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22197102}.
CC   -!- SIMILARITY: Belongs to the FPP/GGPP synthase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF456138; AAL67739.1; -; Genomic_DNA.
DR   EMBL; DQ241785; ABB51993.1; -; Genomic_DNA.
DR   SMR; P0DV09; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004659; F:prenyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030420; P:establishment of competence for transformation; IEA:UniProtKB-KW.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IEA:InterPro.
DR   Gene3D; 1.10.600.10; -; 1.
DR   InterPro; IPR033965; ComQ.
DR   InterPro; IPR008949; Isoprenoid_synthase_dom_sf.
DR   InterPro; IPR000092; Polyprenyl_synt.
DR   Pfam; PF00348; polyprenyl_synt; 1.
DR   SFLD; SFLDG01211; Competence_Regulatory_Protein; 1.
DR   SUPFAM; SSF48576; SSF48576; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Competence; Magnesium; Membrane; Metal-binding;
KW   Prenyltransferase; Transferase.
FT   CHAIN           1..279
FT                   /note="Tryptophan prenyltransferase ComQ"
FT                   /id="PRO_0000454302"
FT   BINDING         67
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P14324"
FT   BINDING         67
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P14324"
FT   BINDING         71
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P14324"
FT   BINDING         71
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P14324"
FT   MUTAGEN         49
FT                   /note="I->A: No change in ComX production or secretion."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         63
FT                   /note="F->S: Shows substantial farnesylation activity when
FT                   FPP is used, while geranylation activity is severely
FT                   reduced."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         68
FT                   /note="D->E: Severely impairs prenylation activity."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         92
FT                   /note="T->L: No change in ComX production or secretion."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         134
FT                   /note="P->S: No change in ComX production or secretion."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         152
FT                   /note="T->I: No change in ComX production or secretion."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         182
FT                   /note="K->F: Retains 37% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:25036949"
FT   MUTAGEN         183..184
FT                   /note="QL->AA: Retains 65% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:25036949"
FT   MUTAGEN         186
FT                   /note="N->A: Retains 20% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:25036949"
FT   MUTAGEN         186
FT                   /note="N->D: Retains 9% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:25036949"
FT   MUTAGEN         186
FT                   /note="N->G: Cannot activate ComX."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         187
FT                   /note="D->A,E,N: Almost loss of activity."
FT                   /evidence="ECO:0000269|PubMed:25036949"
FT   MUTAGEN         188
FT                   /note="Y->A: Retains 54% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:25036949"
FT   MUTAGEN         189
FT                   /note="Y->A: Retains 47% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:25036949"
FT   MUTAGEN         190
FT                   /note="G->A: Retains 87% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:25036949"
FT   MUTAGEN         190
FT                   /note="G->D: Retains 75% of wild-type activity."
FT                   /evidence="ECO:0000269|PubMed:25036949"
FT   MUTAGEN         190
FT                   /note="G->V: Cannot activate ComX."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         202
FT                   /note="K->N: No change in ComX production or secretion."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         234
FT                   /note="S->K: No change in ComX production or secretion."
FT                   /evidence="ECO:0000269|PubMed:31670609"
FT   MUTAGEN         248
FT                   /note="E->K: No change in ComX production or secretion."
FT                   /evidence="ECO:0000269|PubMed:31670609"
SQ   SEQUENCE   279 AA;  32015 MW;  16F332B5A682066B CRC64;
     MKEIVHEKIQ NLDLKEYLIN FIDEKNHFSF GILSFKHYVA LSGNRSSHIL TLAGGIELLI
     LAFDIFDDLE DEDNIEIKWM KIDPSLALNA ATTLYTLGLE TICSISNSAE FHRLTLKYAL
     NAMQGQHEDL RNSPETEEEC IQMMKQKAGS LTAMSAVLAA MLANGEFNQT IEDYAYKIGI
     IKQLENDYYG LVNDQRSDIR KKRKTLIYLF LNRKFNEASE KILKLINSHT SYHSFISDSS
     KFDELLFEAG LNQYVSMLIK LYEEEITASM NQLNINIKL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024